Sbarro Health Research Organization

Home
United States
Philadelphia, PA
Sbarro Health Research Organization

Directions Website

Real Research Real Results. Together We Can Find a Cure For Cancer.
(2)

The Sbarro Health Research Organization (SHRO) is a nonprofit charity organization specialized in conducting research in cancer, diabetes, and cardiovascular disease and to foster the training of young doctors in a spirit of professionalism and humanism. The Sbarro Health Research Organization is a nonprofit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism.

10/13/2026

4 days remaining.

How will translational research, oncology, and precision medicine shape the future of healthcare? The answers at One Health – An Italian-American Scientific Forum, presented by SHRO and NIAF together with Giovan Giacomo Giordano Foundation.

Curated by Dr. Antonio Giordano, President of SHRO and NIAF Board Member.

October 17 | Washington Hilton

10/12/2026

5 days to go.

The One Health – An Italian-American Scientific Forum is approaching.

Join us in celebrating the convergence of Italian medical excellence and American innovation, with a special focus on women’s health and translational research.

October 17 | Washington, D.C.

10/11/2026

6 days to go until SHRO and NIAF present One Health together with Giovan Giacomo Giordano Foundation – An Italian-American Scientific Forum: Shaping the Future of Medicine.

On October 17, leaders in science, medicine, and innovation will gather in Washington, D.C. to explore how biology, environment, technology, and human experience are redefining healthcare.

The future of medicine is taking shape.

10/10/2026

We are honored to announce that Attilio Di Spiezio Sardo, MD, PhD, Professor of Obstetrics and Gynecology at the University of Naples Federico II, Naples, and internationally recognized leader in minimally invasive gynecologic surgery and hysteroscopy, will be the recipient of the Giovan Giacomo Giordano Award for Medical Excellence.

Professor Di Spiezio Sardo will deliver a keynote speech titled “Innovative Treatments for Women’s Health”, highlighting groundbreaking advances in minimally invasive surgery and their transformative impact on patient care.

The award recognizes Professor Di Spiezio Sardo’s distinguished contributions to Italian medicine and his international influence in gynecologic surgery. His scientific, educational, and surgical achievements exemplify the global reach of Italian medical excellence and its growing recognition within the American and international medical communities.

One Health – An Italian-American Scientific Forum: Shaping the Future of Medicine.

10/09/2026

We are honored to announce that Francesco De Seta, MD, PhD, Professor of Obstetrics and Gynecology at Vita-Salute San Raffaele University, Milan, and Head of Women’s Health for the Italian-American One Health Initiative at SHRO, will be the recipient of the SHRO Healthcare Leadership Award.

Professor De Seta will deliver a keynote speech titled “The Woman as an Ecosystem: The Microbiome in Women’s Health”, exploring how the microbiome shapes female health and opens new frontiers for prevention and personalized care.

The award recognizes Professor De Seta’s outstanding contributions to women’s health and his leadership in advancing a new model of Italian-American scientific cooperation. His work exemplifies the translation of Italian clinical and academic excellence into a shared international vision for research, education, and innovation.

One Health – An Italian-American Scientific Forum: Shaping the Future of Medicine.

10/08/2026

SHRO and NIAF are proud to present - together with Giovan Giacomo Giordano Foundation - the complete lineup of speakers for One Health – An Italian-American Scientific Forum: Shaping the Future of Medicine.

Together, we will explore how translational research, oncology, and precision medicine are shaping the future of healthcare through the lens of One Health.

October 17, 2026 | 8:30 AM – 10:00 AM

Jefferson West on the Concourse Level at Washington Hilton, 1919 Connecticut Avenue, NW Washington, D.C.

10/07/2026

SHRO extends its deepest gratitude to the partners supporting One Health together with Giovan Giacomo Giordano Foundation – An Italian-American Scientific Forum: Shaping the Future of Medicine.

Your commitment to research, innovation, and scientific collaboration makes it possible to advance a new vision of healthcare.

Thank you for standing with us in building the future of medicine.

10/06/2026

Gaia Insinga completes a visiting research period at SHRO 🧬

As Gaia Insinga completes her visiting research period at the Sbarro Health Research Organization, we are pleased to acknowledge her contribution to our scientific community.

Insinga is a PhD student at the University of Campania “Luigi Vanvitelli” in Italy. During her time at SHRO, she participated in the organization’s research activities and contributed to an international environment of scientific and academic exchange.

Her experience at SHRO reflects the value of academic mobility in doctoral training, offering early-career researchers the opportunity to engage with new methods, perspectives, and scientific communities.

We thank Gaia for her contributions during this period and look forward to following the continued development of her scientific work.

10/03/2026

SHRO is proud to announce its participation in the 51st Anniversary of the NIAF – National Italian American Foundation, taking place on Saturday, October 17, 2026, at the Washington Hilton in Washington, D.C.

During the morning session, SHRO and NIAF will present One Health – An Italian-American Scientific Forum: Shaping the Future of Medicine.

The future of medicine will not be defined by medicine alone. Biology, environment, technology, prevention, and human experience are increasingly converging into a new understanding of health. Through the lens of One Health, this year’s forum brings Italian medical excellence and American innovation into the same conversation, honoring two distinguished leaders in women’s health while unveiling a new translational initiative in USA.

Curated by Dr. Antonio Giordano, SHRO President and NIAF Board Member, the conference will explore how translational research, oncology, and precision medicine are shaping the future of healthcare.

Stay tuned for further updates.

•••

SHRO è orgogliosa di annunciare la sua partecipazione al 51° Anniversario della NIAF – National Italian American Foundation, che si terrà sabato 17 ottobre 2026 al Washington Hilton di Washington, D.C.

Durante la sessione mattutina, SHRO e NIAF presenteranno One Health – An Italian-American Scientific Forum: Shaping the Future of Medicine.

Il futuro della medicina non dipende più solo dai farmaci o dalle cure tradizionali. Oggi, biologia, ambiente, tecnologia, prevenzione ed esperienza umana si stanno intrecciando per dare vita a una visione più ampia e integrata della salute. Con l’approccio One Health, il forum di quest’anno mette a confronto l’eccellenza medica italiana e l’innovazione americana, rendendo omaggio a due illustri leader nella salute della donna e presentando al contempo una nuova iniziativa di ricerca traslazionale negli Stati Uniti.

Curata dal Dr. Antonio Giordano, Presidente di SHRO e Board Member di NIAF, la conferenza esplorerà come la ricerca traslazionale, l’oncologia e la medicina di precisione stiano plasmando il futuro dell’assistenza sanitaria.

Restate sintonizzati.

10/01/2026

🇺🇸 Breast Cancer Awareness Month 🎀

Recent data confirm the value of prevention and early diagnosis: when breast cancer is detected at the localized stage, the 5-year survival rate exceeds 99%. In the United States, the overall 5-year relative survival rate for breast cancer is 92%, but for localized (early-stage) disease it reaches over 99%. Regular screening and attention to one’s body remain fundamental tools for detecting the disease in its earliest stages, when the chances of cure are highest.

SHRO invests in translational research projects that integrate laboratory and clinical work, with the goal of developing biomarkers for early diagnosis, targeted therapies, and personalized approaches. So that every scientific advancement can become a real opportunity for care.

This Breast Cancer Awareness Month, we reaffirm our commitment: to work with rigor, transparency, and collaboration to bring research ever closer to people.

Address

BioLife Science Bldg, 1900 N 12th Street
Philadelphia, PA
19122

Website

https://twitter.com/sbarro_health, https://drantoniogiordano.com/, http://www.shro.org/, https://www.instagram.com/sbarr

Alerts

Be the first to know and let us send you an email when Sbarro Health Research Organization posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.